A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia. | MicrobiomeTrials← Back to trialsNCT06732895
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-12-10Est. Completion: 2027-09
Enrollment target: 25 participants Locations- Ascendis Investigational Site, Montreal, Canada
- Ascendis Investigational Site, Copenhagen, Denmark
- Ascendis Investigational Site, Paris, France
- Ascendis Investigational Site, Dublin, Ireland
- Ascendis Investigational Site, Norwich, United Kingdom
Other microbiome trials you might be interested in
Achondroplasia
This is a Phase 2, multicenter, open-label, extension (OLE) study to evaluate the long-term safety, tolerability, and ef…
Oakland, United StatesCompleted Dec 1, 2031
Achondroplasia
This is a multicenter, multinational, randomized, active-controlled, operationally seamless Phase 2/3 study of BMN 333 i…
Oakland, United StatesEst. completion Jun 2029